Corrigendum to “Biological markers evaluated in randomized trials of psychological treatments for depression: A systematic review and meta-analysis” [Neurosci. Biobehav. Rev. 101 (2019) 32–44](S0149763419300247)(10.1016/j.neubiorev.2019.03.022);Biological markers evaluated in randomized trials of psychological treatments for depression: a systematic review and meta-analysis

Neuroscience and Biobehavioral Reviews

Volumn 101, Issue , 2019, Pages 32-44

  Cristea, Ioana A ^a   Karyotaki, Eirini ^b   Hollon, Steven D ^c   Cuijpers, Pim ^d   Gentili, Claudio ^d  

^a BABE BOLYAI UNIVERSITY   (Romania)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Biomarkers; Depression; Meta analysis; Psychotherapy; Randomized controlled trial

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; HEMOGLOBIN A1C; HYDROCORTISONE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; BLOOD PRESSURE; BODY MASS; COGNITIVE BEHAVIORAL THERAPY; DEPRESSION; FUNCTIONAL CONNECTIVITY; GENETIC POLYMORPHISM; GLYCEMIC CONTROL; HUMAN; MAJOR DEPRESSION; META ANALYSIS; MINDFULNESS; NEUROIMAGING; PRIORITY JOURNAL; PSYCHOTHERAPY; REMISSION; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE; BRAIN; DIAGNOSTIC IMAGING; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

BIOMARKERS; BRAIN; DEPRESSION; DEPRESSIVE DISORDER; GLYCATED HEMOGLOBIN A; HUMANS; HYDROCORTISONE; NEUROIMAGING; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 85063762934     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2019.06.004     Document Type: Erratum

References (96)

1. Ahmadpanah, M., Paghale, S.J., Bakhtyari, A., Kaikhavani, S., Aghaei, E., Nazaribadie, M., Holsboer-Trachsler, E., Brand, S., Effects of psychotherapy in combination with pharmacotherapy, when compared to pharmacotherapy only on blood pressure, depression, and anxiety in female patients with hypertension. J. Health Psychol. 21 (2016), 1216–1227.
2. Barr Taylor, C., Conrad, A., Wilhelm, F.H., Strachowski, D., Khaylis, A., Neri, E., Giese-Davis, J., Roth, W.T., Cooke, J.P., Kraemer, H., Spiegel, D., Does improving mood in depressed patients alter factors that may affect cardiovascular disease risk?. J. Psychiatr. Res. 43 (2009), 1246–1252.
3. Beevers, C.G., Clasen, P.C., Enock, P.M., Schnyer, D.M., Attention bias modification for major depressive disorder: effects on attention bias, resting state connectivity, and symptom change. J. Abnorm. Psychol., 2015, 463–475.
4. Beutler, L.E., Scogin, F., Kirkish, P., Schretlen, D., Corbishley, A., Hamblin, D., Levenson, A.I., Group cognitive therapy and alprazolam in the treatment of depression in older adults. J. Consult Clin. Psychol. 55:4 (1987), 550–556.
5. Boccia, M., Piccardi, L., Guariglia, P., How treatment affects the brain: meta-analysis evidence of neural substrates underpinning drug therapy and psychotherapy in major depression. Brain Imaging Behav. 10 (2016), 619–627.
6. Brooks, S.J., Stein, D.J., A systematic review of the neural bases of psychotherapy for anxiety and related disorders. Dialogues Clin. Neurosci. 17 (2015), 261–279.
7. Chan, A.S., Cheung, M.C., Tsui, W.J., Sze, S.L., Shi, D., Dejian mind-body intervention on depressive mood of community-dwelling adults: A randomized controlled trial. Evid.-Based Complement. Altern. Med., 2011.
8. Cole, J., Costafreda, S.G., McGuffin, P., Fu, C.H., Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. J. Affect. Disord. 134 (2011), 483–487.
9. Crettol, S., de Leon, J., Hiemke, C., Eap, C.B., Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine. Clin. Pharmacol. Ther. 95 (2014), 254–257.
10. Cristea, I.A., Huibers, M.J., David, D., Hollon, S.D., Andersson, G., Cuijpers, P., The effects of cognitive behavior therapy for adult depression on dysfunctional thinking: a meta-analysis. Clin. Psychol. Rev. 42 (2015), 62–71.
11. Cuijpers, P., Cristea, I.A., Karyotaki, E., Reijnders, M., Huibers, M.J., How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry 15 (2016), 245–258.
12. Cuijpers, P., Karyotaki, E., Reijnders, M., Huibers, M.J.H., Who benefits from psychotherapies for adult depression? A meta-analytic update of the evidence. Cogn. Behav. Ther. 47 (2018), 91–106.
13. Cuijpers, P., Reijnders, M., Karyotaki, E., (Under review). Psychological treatment of depression: An updated meta-analytic database of randomized trial. BMC Psychiatry.
14. Dekkers, O.M., Elm, Ev., Algra, A., Romijn, J.A., Vandenbroucke, J.P., How to assess the external validity of therapeutic trials: a conceptual approach. Int. J. Epidemiol. 39 (2009), 89–94.
15. DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control. Clin. Trials 7 (1986), 177–188.
16. Doering, L.V., Cross, R., Vredevoe, D., Martinez-Maza, O., Cowan, M.J., Infection, depression, and immunity in women after coronary artery bypass: a pilot study of cognitive behavioral therapy. Altern. Ther. Health Med. 13 (2007), 18–21.
17. Dunlop, B.W., Mayberg, H.S., Neuroimaging-based biomarkers for treatment selection in major depressive disorder. Dialogues Clin. Neurosci. 16 (2014), 479–490.
18. Dunlop, B.W., Rajendra, J.K., Craighead, W.E., Kelley, M.E., McGrath, C.L., Choi, K.S., Kinkead, B., Nemeroff, C.B., Mayberg, H.S., Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder. Am. J. Psychiatry 174 (2017), 533–545.
19. Ebert, D., Nobis, S., Lehr, D., Baumeister, H., Riper, H., Auerbach, R., Snoek, F., Cuijpers, P., Berking, M., The 6-month effectiveness of Internet-based guided self-help for depression in adults with Type 1 and 2 diabetes mellitus. Diabet. Med., 2017, 99–107.
20. Euteneuer, F., Dannehl, K., Del Rey, A., Engler, H., Schedlowski, M., Rief, W., Immunological effects of behavioral activation with exercise in major depression: an exploratory randomized controlled trial. Transl. Psychiatry, 7, 2017.
21. Field, T., Diego, M.A., Hernandez-Reif, M., Schanberg, S., Kuhn, C., Massage therapy effects on depressed pregnant women. J. Psychosom. Obstet. Gynaecol. 25 (2004), 115–122.
22. Field, T., Diego, M., Delgado, J., Medina, L., Peer support and interpersonal psychotherapy groups experienced decreased prenatal depression, anxiety and cortisol. Early Hum. Dev. 89 (2013), 621–624.
23. Fiest, K.M., Walker, J.R., Bernstein, C.N., Graff, L.A., Zarychanski, R., Abou-Setta, A.M., Patten, S.B., Sareen, J., Bolton, J.M., Marriott, J.J., Fisk, J.D., Singer, A., Marrie, R.A., Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult. Scler. Relat. Disord. 5 (2016), 12–26.
24. Fissler, M., Winnebeck, E., Schroeter, T.A., Gummbersbach, M., Huntenburg, J.M., Gärtner, M., Barnhofer, T., Brief training in mindfulness may normalize a blunted error-related negativity in chronically depressed patients. Cogn. Affect. Behav. Neurosci. 17 (2017), 1164–1175.
25. Fonseka, T.M., MacQueen, G.M., Kennedy, S.H., Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder. J. Affect. Disord. 233 (2018), 21–35.
26. Franklin, G., Carson, A.J., Welch, K.A., Cognitive behavioural therapy for depression: systematic review of imaging studies. Acta Neuropsychiatr. 28 (2016), 61–74.
27. Freedland, K.E., Carney, R.M., Rich, M.W., Steinmeyer, B.C., Rubin, E.H., Cognitive behavior therapy for depression and self-care in heart failure patients a randomized clinical trial. JAMA Intern. Med. 175 (2015), 1773–1782.
28. Frieling, H., Tadic, A., Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment. Int. Rev. Psychiatry (Abingdon, England) 25 (2013), 572–578.
29. Fu, C.H., Williams, S.C., Cleare, A.J., Scott, J., Mitterschiffthaler, M.T., Walsh, N.D., Donaldson, C., Suckling, J., Andrew, C., Steiner, H., Murray, R.M., Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol. Psychiatry 64 (2008), 505–512.
30. Furtado, M., Katzman, M.A., Examining the role of neuroinflammation in major depression. Psychiatry Res. 229 (2015), 27–36.
31. Gentili, C., Why do we keep failing in identifying reliable biological markers in depression?. J. Evid. Psychother., 17, 2017, 6.
32. Gois, C., Dias, V.V., Carmo, I., Duarte, R., Ferro, A., Santos, A.L., Sousa, F., Barbosa, A., Treatment response in type 2 diabetes patients with major depression. Clin. Psychol. Psychother. 21 (2014), 39–48.
33. Guyatt, G.H., Oxman, A.D., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., Montori, V., Akl, E.A., Djulbegovic, B., Falck-Ytter, Y., Norris, S.L., Williams, J.W. Jr., Atkins, D., Meerpohl, J., Schünemann, H.J., GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias). J. Clin. Epidemiol. 64 (2011), 407–415.
34. Harley, J., Luty, S., Carter, J., Mulder, R., Joyce, P., Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy. J. Psychopharmacol. (Oxford, England) 24 (2010), 625–626.
35. Harley, J., Luty, S., Carter, J., Mulder, R., Joyce, P., Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy. J. Psychopharmacol. 24 (2010), 625–626.
36. Harris, R.J., Bradburn, M.J., Deeks, J.J., Harbord, R.M., Altman, D.G., Steichen, T., Sterne, J.A.C., METAN: Stata Module for Fixed and Random Effects Meta-analysis. 9 ed., 2010, Boston College Department of Economics.
37. Herbert, J., Cortisol and depression: three questions for psychiatry. Psychol. Med. 43 (2013), 449–469.
38. Higgins, J.P., Green, S., Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration. 2011.
39. Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
40. Higgins, J.P.T., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., Savović, J., Schulz, K.F., Weeks, L., Sterne, J.A.C., The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011.
41. Hirvonen, J., Hietala, J., Kajander, J., Markkula, J., Rasi-Hakala, H., Salminen, J.K., Nagren, K., Aalto, S., Karlsson, H., Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclopride PET. J. Psychopharmacol. (Oxford, England) 25 (2011), 1329–1336.
42. Howells, F.M., Laurie Rauch, H.G., Ives-Deliperi, V.L., Horn, N.R., Stein, D.J., Mindfulness based cognitive therapy may improve emotional processing in bipolar disorder: pilot ERP and HRV study. Metab. Brain Dis. 29 (2014), 367–375.
43. Hsiao, F.H., Jow, G.M., Lai, Y.M., Chen, Y.T., Wang, K.C., Ng, S.M., Ho, R.T., Chan, C.L., Yang, T.T., The long-term effects of psychotherapy added to pharmacotherapy on morning to evening diurnal cortisol patterns in outpatients with major depression. Psychother. Psychosom. 80 (2011), 166–172.
44. Hsiao, F.-H., Lai, Y.-M., Chen, Y.-T., Yang, T.-T., Liao, S.-C., Ho, R.T., Ng, S.-M., Chan, C.L., Jow, G.-M., Efficacy of psychotherapy on diurnal cortisol patterns and suicidal ideation in adjustment disorder with depressed mood. Gen. Hosp. Psychiatry 36 (2014), 214–219.
45. Huang, C.-Y., Lai, H.-L., Chen, C.-I., Lu, Y.-C., Li, S.-C., Wang, L.-W., Su, Y., Effects of motivational enhancement therapy plus cognitive behaviour therapy on depressive symptoms and health-related quality of life in adults with type II diabetes mellitus: a randomised controlled trial. Qual. Life Res. 25 (2016), 1275–1283.
46. Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335 (2007), 914–916.
47. Joyce, P.R., Mulder, R.T., Luty, S.E., Sullivan, P.F., McKenzie, J.M., Abbott, R.M., Stevens, I.F., Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Aust. N. Z. J. Psychiatry 36 (2002), 384–391.
48. Karyotaki, E., Smit, Y., Beurs, D.P., Henningsen, K.H., Robays, J., Huibers, M.J.H., Weitz, E., Cuijpers, P., The long-term efficacy of acute-phase psychotherapy for depression: a meta-analysis of randomized trials. Depress. Anxiety 33 (2016), 370–383.
49. Kemp, A.H., Quintana, D.S., Gray, M.A., Felmingham, K.L., Brown, K., Gatt, J.M., Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol. Psychiatry 67 (2010), 1067–1074.
50. Kennedy, S.H., Konarski, J.Z., Segal, Z.V., Lau, M.A., Bieling, P.J., McIntyre, R.S., Mayberg, H.S., Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am. J. Psychiatry 164 (2007), 778–788.
51. Kohen, R., Cain, K.C., Buzaitis, A., Johnson, V., Becker, K.J., Teri, L., Tirschwell, D.L., Veith, R.C., Mitchell, P.H., Response to psychosocial treatment in poststroke depression is associated with serotonin transporter polymorphisms. Stroke 42 (2011), 2068–2070.
52. Kontopantelis, E., Reeves, D., METAEFF: Stata Module to Perform Effect Sizes Calculations for Meta-Analyses. 2009, Boston College Department of Economics.
53. Lamers, F., Jonkers, C.C., Bosma, H., Knottnerus, J.A., Eijk, J.T., Treating depression in diabetes patients: does a nurse-administered minimal psychological intervention affect diabetes-specific quality of life and glycaemic control? A randomized controlled trial. J. Adv. Nurs., 2011, 788–799.
54. Lesperance, F., Frasure-Smith, N., Koszycki, D., Laliberte, M.A., van Zyl, L.T., Baker, B., Swenson, J.R., Ghatavi, K., Abramson, B.L., Dorian, P., Guertin, M.C., Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. Jama 297 (2007), 367–379.
55. Linde, J.A., Simon, G.E., Ludman, E.J., Ichikawa, L.E., Operskalski, B.H., Arterburn, D., Rohde, P., Finch, E.A., Jeffery, R.W., A randomized controlled trial of behavioral weight loss treatment versus combined weight loss/depression treatment among women with comorbid obesity and depression. Ann. Behav. Med. 41 (2011), 119–130.
56. Lipska, K.J., Krumholz, H.M., Is hemoglobin a1c the right outcome for studies of diabetes?. Jama 317 (2017), 1017–1018.
57. Lustman, P.J., Griffith, L.S., Freedland, K.E., Kissel, S.S., Clouse, R.E., Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann. Intern. Med. 129 (1998), 613–621.
58. Luty, S.E., Carter, J.D., McKenzie, J.M., Rae, A.M., Frampton, C.M., Mulder, R.T., Joyce, P.R., Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br. J. Psychiatry 190 (2007), 496–502.
59. Markowitz, J.C., Kocsis, J.H., Fishman, B., Spielman, L.A., Jacobsberg, L.B., Frances, A.J., Klerman, G.L., Perry, S.W., Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Arch. Gen. Psychiatry 55 (1998), 452–457.
60. Martin, S.D., Martin, E., Rai, S.S., Richardson, M.A., Royall, R., Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch. Gen. Psychiatry 58 (2001), 641–648.
61. McGrath, C.L., Kelley, M.E., Holtzheimer, P.E., Dunlop, B.W., Craighead, W.E., Franco, A.R., Craddock, R.C., Mayberg, H.S., Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry 70 (2013), 821–829.
62. McKnight, D.L., Nelson-Gray, R.O., Barnhill, J., Dexamethasone suppression test and response to cognitive therapy and antidepressant medication. Behav. Ther. 23 (1992), 99–111.
63. Messina, I., Sambin, M., Palmieri, A., Viviani, R., Neural correlates of psychotherapy in anxiety and depression: a meta-analysis. PLoS One, 8, 2013, e74657.
64. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J. Clin. Epidemiol. 62 (2009), 1006–1012.
65. Mohr, D.C., Boudewyn, A.C., Goodkin, D.E., Bostrom, A., Epstein, L., Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J. Consult. Clin. Psychol. 69 (2001), 942–949.
66. Mohr, D.C., Goodkin, D.E., Islar, J., Hauser, S.L., Genain, C.P., Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Arch. Neurol. 58 (2001), 1081–1086.
67. Moore, M.T., Fresco, D.M., Segal, Z.V., Brown, T.A., An exploratory analysis of the factor structure of the Dysfunctional Attitude Scale-Form A (DAS). Assessment 21 (2014), 570–579.
68. Newby, J., Robins, L., Wilhelm, K., Smith, J., Fletcher, T., Gillis, I., Ma, T., Finch, A., Campbell, L., Andrews, G., Web-based cognitive behavior therapy for depression in people with diabetes mellitus: a randomized controlled trial. J. Med. Internet Res., 2017, e157.
69. Nolan, R.P., Jong, P., Barry-Bianchi, S.M., Tanaka, T.H., Floras, J.S., Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: a systematic review. Eur. J. Cardiovasc. Prevent. Rehab. 15 (2008), 386–396.
70. Orsini, N., Bottai, M., Higgins, J., Buchan, I., HETEROGI: Stata Module to Quantify Heterogeneity in a Meta-Analysis. 2006.
71. Pagoto, S., Schneider, K.L., Whited, M.C., Oleski, J.L., Merriam, P., Appelhans, B., Ma, Y., Olendzki, B., Waring, M.E., Busch, A.M., Lemon, S., Ockene, I., Crawford, S., Randomized controlled trial of behavioral treatment for comorbid obesity and depression in women: the Be Active Trial. Int. J. Obes. 2005:37 (2013), 1427–1434.
72. Papakostas, G.I., Fava, M., Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues Clin. Neurosci. 10 (2008), 439–451.
73. Parker, J.C., Smarr, K.L., Slaughter, J.R., Johnston, S.K., Priesmeyer, M.L., Hanson, K.D., Johnson, G.E., Hewett, J.E., Hewett, J.E., Irvin, W.S., Komatireddy, G.R., Walker, S.E., Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach. Arthritis Rheum. 49 (2003), 766–777.
74. Penckofer, S.M., Ferrans, C., Mumby, P., Byrn, M., Emanuele, M.A., Harrison, P.R., Durazo-Arvizu, R.A., Lustman, P., A psychoeducational intervention (SWEEP) for depressed women with diabetes. Ann. Behav. Med. 44 (2012), 192–206.
75. Pentecost, C., Farrand, P., Greaves, C.J., Taylor, R.S., Warren, F.C., Hillsdon, M., Green, C., Welsman, J.R., Rayson, K., Evans, P.H., Taylor, A.H., Combining behavioural activation with physical activity promotion for adults with depression: findings of a parallel-group pilot randomised controlled trial (BAcPAc). Trials, 2015.
76. Petrak, F., Herpertz, S., Albus, C., Hermanns, N., Hiemke, C., Hiller, W., Kronfeld, K., Kruse, J., Kulzer, B., Ruckes, C., Zahn, D., Muller, M.J., Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes: the diabetes and depression (DAD) study: a randomized controlled multicenter trial. Diabetes Care 38 (2015), 767–775.
77. Pibernik-Okanovic, M., Begic, D., Ajdukovic, D., Andrijasevic, N., Metelko, Z., Psychoeducation versus treatment as usual in diabetic patients with subthreshold depression: preliminary results of a randomized controlled trial. Trials, 10, 2009, 78.
78. Pibernik-Okanovic, M., Hermanns, N., Ajdukovic, D., Kos, J., Prasek, M., Sekerija, M., Lovrencic, M.V., Does treatment of subsyndromal depression improve depression-related and diabetes-related outcomes? A randomised controlled comparison of psychoeducation, physical exercise and enhanced treatment as usual. Trials, 16, 2015, 305.
79. Rahman, M.S., Millischer, V., Zeebari, Z., Forsell, Y., Lavebratt, C., BDNF Val66Met and childhood adversity on response to physical exercise and internet-based cognitive behavioural therapy in depressed Swedish adults. J. Psychiatr. Res. 93 (2017), 50–58.
80. Rovner, B.W., Casten, R.J., Hegel, M.T., Massof, R.W., Leiby, B.E., Ho, A.C., Tasman, W.S., Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial. Ophthalmology 121 (2014), 2204–2211.
81. Safren, S.A., O'Cleirigh, C., Tan, J.Y., Raminani, S.R., Reilly, L.C., Otto, M.W., Mayer, K.H., A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 28 (2009), 1–10.
82. Safren, S.A., O'Cleirigh, C.M., Bullis, J.R., Otto, M.W., Stein, M.D., Pollack, M.H., Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J. Consult. Clin. Psychol. 80 (2012), 404–415.
83. Safren, S.A., Gonzalez, J.S., Wexler, D.J., Psaros, C., Delahanty, L.M., Blashill, A.J., Margolina, A.I., Cagliero, E., A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care 37 (2014), 625–633.
84. Safren, S.A., Bedoya, C.A., O'Cleirigh, C., Biello, K.B., Pinkston, M.M., Stein, M.D., Traeger, L., Kojic, E., Robbins, G.K., Lerner, J.A., Herman, D.S., Mimiaga, M.J., Mayer, K.H., Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial. Lancet HIV 3 (2016), e529–e538.
85. Savard, J., Simard, S., Giguere, I., Ivers, H., Morin, C.M., Maunsell, E., Gagnon, P., Robert, J., Marceau, D., Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects. Palliat. Support. Care 4 (2006), 219–237.
86. Scammacca, N., Roberts, G., Stuebing, K.K., Meta-analysis with complex research designs:dealing with dependence from multiple measures and multiple group comparisons. Rev. Educ. Res. 84 (2014), 328–364.
87. Schneider, L.S., Sloane, R.B., Staples, F.R., Bender, M., Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression. J. Clin. Psychopharmacol. 6 (1986), 172–176.
88. Schramm, P.J., Zobel, I., Mönch, K., Schramm, E., Michalak, J., Sleep quality changes in chronically depressed patients treated with mindfulness-based cognitive therapy or the cognitive behavioral analysissystem of psychotherapy: a pilot study. Sleep Medicine 17 (2016), 57–63.
89. Simoni, J.M., Wiebe, J.S., Sauceda, J.A., Huh, D., Sanchez, G., Longoria, V., Andres Bedoya, C., Safren, S.A., A preliminary RCT of CBT-AD for adherence and depression among HIV-positive Latinos on the U.S.-Mexico border: the Nuevo Dia study. AIDS Behav. 17 (2013), 2816–2829.
90. Tovote, K.A., Fleer, J., Snippe, E., Peeters, A., Emmelkamp, P.M.G., Sanderman, R., Links, T.P., Schroevers, M.J., Individual mindfulness-based cognitive therapy and cognitive behavior therapy for treating depressive symptoms in patients with diabetes: results of a randomized controlled trial. Diabetes Care, 2014, 2427–2434.
91. Uchendu, C., Blake, H., Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabetic Med., 2016.
92. Urizar, G.G. Jr., Munoz, R.F., Impact of a prenatal cognitive-behavioral stress management intervention on salivary cortisol levels in low-income mothers and their infants. Psychoneuroendocrinology 36 (2011), 1480–1494.
93. van Bastelaar, K.M., Pouwer, F., Cuijpers, P., Riper, H., Snoek, F.J., Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 34 (2011), 320–325.
94. Yang, T.T., Hsiao, F.H., Wang, K.C., Ng, S.M., Ho, R.T., Chan, C.L., Lai, Y.M., Chen, Y.T., The effect of psychotherapy added to pharmacotherapy on cortisol responses in outpatients with major depressive disorder. J. Nerv. Ment. Dis. 197 (2009), 401–406.
95. Zapf, A., Castell, S., Morawietz, L., Karch, A., Measuring inter-rater reliability for nominal data - which coefficients and confidence intervals are appropriate?. BMC Med. Res. Methodol., 16, 2016 93-93.
96. Zorn, J.V., Schür, R.R., Boks, M.P., Kahn, R.S., Joëls, M., Vinkers, C.H., Cortisol stress reactivity across psychiatric disorders: a systematic review and meta-analysis. Psychoneuroendocrinology 77 (2017), 25–36.